HRTX Stock Analysis: Buy, Sell, or Hold?
HRTX - Heron Therapeutics, Inc.
$0.80
0.00 (0.42%)
▲
5d:
+0.9%
30d:
-30.13%
90d:
-40.48%
BUY
HIGH Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When HRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HRTX trading at deep discount. Market pricing in -4.1% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: HRTX trading at deep discount. Market pricing in -4.1% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.29
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.80
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HRTX is currently trading at $0.80, which is considered oversold relative to its 30-day fair value range of $0.82 to $1.13. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.6) compared to its historical average (1.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HRTX is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $0.87.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.33 (+439.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HRTX is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $0.87.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.33 (+439.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.82 -
$1.13
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 439.3% below Wall St target ($4.33)
Fair Price Analysis
30-Day Fair Range
$0.82 -
$1.13
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$0.87
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.58
Wall Street Target
$4.33
(+439.3%)
Revenue Growth (YoY)
-0.5%
Profit Margin
-13.0%
Valuation Discount vs History
-4.1% cheaper
PE vs Historical
1.6 vs 1.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.1%
(market-implied from PE analysis)
1-Year Target
$0.77
(-4%)
2-Year Target
$0.74
(-8%)
3-Year Target
$0.71
(-12%)
3-Yr Target (if PE normalizes)
(PE: 2→2)
$0.81
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.6 to 1.8
Stabilization Target:
$0.92
(+14.3%)
PE Expansion Potential:
+14.3%
Share & Embed Analysis
Last updated: April 02, 2026 4:18 AM ET
Data refreshes hourly during market hours. Next update: 5:18 AM
Data refreshes hourly during market hours. Next update: 5:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 66 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 45 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
15 analysts |
$669 | 63 BUY |
